REGN

REGN Net Income Growth

-2.91%TTM

Period ending:

REGN TTM Net Income YoY %%
REGN TTM Net Income YoY %3736.51%-1871.88%
1991-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

REGN net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 139 observations from Dec 31, 1991 to Jun 30, 2026.

Regeneron Pharmaceuticals Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-2.9135%
-1.6869%
2.0917%
-1.6436%
3.1677%
16.6286%
11.6097%
16.622%
0.528%
-7.7677%
-8.8696%
-25.682%
-24.4039%
-47.2787%
-46.2757%
-23.2321%
-8.3572%
98.1518%
129.856%
121.6572%
107.9906%
75.6592%
66.0459%
47.1878%
44.1823%
-6.1076%
-13.4446%
19.2835%
30.0414%
70.0501%
103.957%
40.6428%
37.8171%
48.2304%
36.2141%
63.4926%
58.7407%
32.6959%
38.3326%
32.2229%
57.9264%
102.3608%
82.7359%
76.645%
16.2179%
-8.257%
-17.9771%
-58.0552%
-53.2746%
-53.3212%
-43.4387%
252.4276%
3,193.766%
602.5093%
438.3248%
223.7844%
82.2476%
-41.9693%
-112.2755%
-44.7563%
-65.1594%
-41.4987%
-49.4043%
-94.5437%
-9.9327%
6.3326%
15.46%
-1.0722%
-7.6798%
-1.457%
21.6761%
47.9652%
31.3595%
21.9649%
-3.1885%
-22.2312%
-6.2726%
-0.1531%
-7.2198%
-60.4236%
-174.7805%
-314.3901%
-328.8928%
-422.4885%
-1,329.1329%
-145.4786%
139.4791%
116.0162%
102.5174%
91.4904%
15.0784%
-4.1662%
-22.2487%
-45.6653%
-63.2673%
-103.441%
-155.2044%
-206.1727%
-228.1499%
-286.8042%

Compare net income growth

Other companies in Healthcare. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All REGN financial metrics · REGN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.